Dr. Jonathan Moore, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $381.74 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Terumo Medical Corporation | $155.72 | 1 | $0 (2018) |
| Boston Scientific Corporation | $100.75 | 6 | $0 (2019) |
| GlaxoSmithKline, LLC. | $24.70 | 1 | $0 (2022) |
| Genentech USA, Inc. | $24.28 | 1 | $0 (2020) |
| Lundbeck LLC | $22.74 | 1 | $0 (2018) |
| Allergan Inc. | $20.16 | 1 | $0 (2017) |
| Mission Pharmacal Company | $12.26 | 1 | $0 (2017) |
| Amgen Inc. | $10.77 | 1 | $0 (2018) |
| West-Ward Pharmaceuticals | $10.36 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $24.70 | 1 | GlaxoSmithKline, LLC. ($24.70) |
| 2020 | $24.28 | 1 | Genentech USA, Inc. ($24.28) |
| 2019 | $42.08 | 3 | Boston Scientific Corporation ($42.08) |
| 2018 | $247.90 | 6 | Terumo Medical Corporation ($155.72) |
| 2017 | $42.78 | 3 | Allergan Inc. ($20.16) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: VACCINES | ||||||
| 02/11/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Virology & Specialty Care | ||||||
| 03/13/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/14/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/23/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/15/2018 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/18/2018 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/16/2018 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/20/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: Neuroscience | ||||||
| 04/04/2018 | Lundbeck LLC | ONFI (Drug) | Food and Beverage | Cash or cash equivalent | $22.74 | General |
| Category: NEUROLOGY | ||||||
| 02/22/2018 | Terumo Medical Corporation | AZUR (Device) | Food and Beverage | Cash or cash equivalent | $155.72 | General |
| Category: Vascular Embolization | ||||||
| 07/17/2017 | Allergan Inc. | STRATTICE (Device) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 06/22/2017 | Mission Pharmacal Company | Hycofenix (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Oral antitussive, nasal decongestant and expectorant | ||||||
| 01/16/2017 | West-Ward Pharmaceuticals | Mitigare (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 555 | 1,272 | $53,202 | $20,182 |
| 2022 | 14 | 624 | 1,305 | $59,656 | $29,115 |
| 2021 | 14 | 716 | 1,190 | $56,797 | $31,912 |
| 2020 | 13 | 520 | 1,008 | $41,158 | $19,495 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 70 | $14,320 | $6,134 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $10,742 | $4,305 | 40.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 53 | 55 | $6,046 | $2,715 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 46 | $6,588 | $2,540 | 38.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $3,872 | $1,499 | 38.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 92 | 124 | $3,540 | $1,111 | 31.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 17 | 36 | $1,172 | $583.92 | 49.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 12 | $1,671 | $486.60 | 29.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 14 | $756.00 | $314.92 | 41.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 18 | $662.00 | $126.70 | 19.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 16 | 16 | $192.00 | $121.76 | 63.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 23 | $115.00 | $78.43 | 68.2% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 11 | 11 | $198.00 | $56.44 | 28.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 35 | 148 | $2,960 | $56.00 | 1.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 78 | 621 | $248.40 | $52.00 | 20.9% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2023 | 12 | 15 | $120.00 | $1.37 | 1.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 64 | $9,994 | $6,199 | 62.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 113 | 119 | $17,850 | $6,023 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $9,442 | $5,606 | 59.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 84 | $8,717 | $5,600 | 64.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $3,613 | $2,340 | 64.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 93 | 122 | $3,387 | $1,129 | 33.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 23 | $1,467 | $925.64 | 63.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 23 | 46 | $1,160 | $747.44 | 64.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 13 | 13 | $451.00 | $211.41 | 46.9% |
About Dr. Jonathan Moore, M.D
Dr. Jonathan Moore, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598841322.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Moore, M.D has received a total of $381.74 in payments from pharmaceutical and medical device companies, with $24.70 received in 2022. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($381.74).
As a Medicare-enrolled provider, Moore has provided services to 2,415 Medicare beneficiaries, totaling 4,775 services with total Medicare billing of $100,704. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties General Practice
- Location Mobile, AL
- Active Since 10/27/2006
- Last Updated 08/31/2017
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1598841322
Products in Payments
- AZUR (Device) $155.72
- GENERAL PAIN MANAGEMENT (Device) $58.67
- GENERAL PAIN MANAGEMENT (Device) $42.08
- SHINGRIX (Biological) $24.70
- Xofluza (Drug) $24.28
- ONFI (Drug) $22.74
- STRATTICE (Device) $20.16
- Hycofenix (Drug) $12.26
- Aimovig (Biological) $10.77
- Mitigare (Drug) $10.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Mobile
Dr. William Kilgo, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $168,470
Dr. William Sonnier, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $130,244
Mr. Thomas Turnage, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $80,392
Mrs. Ashleigh Butts-Wilkerson, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $49,440
Dr. Ahmed Subahi, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $36,917
Dr. Brian Wood, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $24,083